Mesoblast (MEOBF) Change in Account Payables (2014 - 2024)
Mesoblast's (MEOBF) quarterly Change in Account Payables came in at -$12.4 million in Q2 2024, down 3010.05% year-over-year from $425353.5 in Q3 2023, and down 3010.05% quarter-over-quarter from -$398000.0 in Q2 2023.
Powered by 
Analysis
Mesoblast (MEOBF) Change in Account Payables (2014 - 2024) Analysis & Trends
Mesoblast has disclosed Change in Account Payables across 11 years of filings, most recently posting -$12.4 million for Q2 2024.
- In Q2 2024, Change in Account Payables fell 3010.05% year-over-year to -$12.4 million; the TTM figure through Jun 2024 stood at -$9.8 million (down 4826.09% YoY), while the FY2026 annual figure was $25.7 million, up 118.06% from the prior year.
- Change in Account Payables came in at -$12.4 million for Q2 2024 at Mesoblast, down from -$398000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.3 million in Q1 2020 to a low of -$12.4 million in Q2 2024.
- Average Change in Account Payables over 5 years is -$438714.3, with a median of -$919500.0 recorded in 2020.
- Year-over-year, Change in Account Payables soared 1346.12% in 2021 and tumbled 3010.05% in 2024.
- Over 5 years, Change in Account Payables stood at -$412000.0 in 2020, then soared by 1346.12% to $5.1 million in 2021, then slipped by 2.69% to $5.0 million in 2022, then slumped by 107.97% to -$398000.0 in 2023, then plunged by 3010.05% to -$12.4 million in 2024.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$12.4 million in Q2 2024, -$398000.0 in Q2 2023, and -$2.0 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 3.06 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -11.82 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2.90 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 625,000.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.21 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 2.84 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -19.39 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1.57 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -12.38 Mn |
| Jun 30, 2023 | -398,000.00 |
| Mar 31, 2023 | -2.00 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | -1.43 Mn |
| Dec 31, 2021 | 5.13 Mn |
| Sep 30, 2021 | -3.02 Mn |
| Jun 30, 2021 | -4.53 Mn |
| Mar 31, 2021 | -3.72 Mn |
| Dec 31, 2020 | -412,000.00 |
| Sep 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 6.31 Mn |
| Dec 31, 2019 | 5.91 Mn |
| Sep 30, 2019 | -300,000.00 |
| Mar 31, 2019 | -7.34 Mn |
| Dec 31, 2018 | 8.77 Mn |
| Sep 30, 2018 | 2.19 Mn |
| Jun 30, 2018 | -2.92 Mn |